<p>The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.</p>
申请公布号
WO2004099144(A1)
申请公布日期
2004.11.18
申请号
WO2004SE00693
申请日期
2004.05.06
申请人
ASTRAZENECA AB;LUCKHURST, CHRISTOPHER;MOCHEL, TOBIAS;PERRY, MATTHEW;SPRINGTHORPE, BRIAN;STEIN, LINDA
发明人
LUCKHURST, CHRISTOPHER;MOCHEL, TOBIAS;PERRY, MATTHEW;SPRINGTHORPE, BRIAN;STEIN, LINDA
